{
  "scores": {
    "rubric_version": "v3.0-2025-10-14",
    "items": {
      "Title": {
        "score": 1,
        "evidence": "Randomised Controlled Trial on Coagulation Management in Cardiothoracic Surgery"
      },
      "Trial_Design": {
        "score": 1,
        "evidence": "Randomisation was achieved through a computer-generated sequence"
      },
      "Participants": {
        "score": 2,
        "evidence": "Participants were eligible if they were scheduled for cardiothoracic surgery and met predefined criteria."
      },
      "Intervention": {
        "score": 2,
        "evidence": "The intervention group received tranexamic acid and heparin, along with nonpharmacological methods such as hemostatic agents, while the control group received standard care."
      },
      "Objective": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Method_Outcome": {
        "score": 2,
        "evidence": "The primary outcome was the reduction in postoperative bleeding, assessed over 24 hours."
      },
      "Randomisation_Allocation": {
        "score": 2,
        "evidence": "Randomisation was achieved through a computer-generated sequence, with allocation concealment via sealed envelopes."
      },
      "Blinding": {
        "score": 1,
        "evidence": "Outcome assessors were blinded to group assignments."
      },
      "Number_Randomised": {
        "score": 2,
        "evidence": "A total of 200 participants were randomised, with 100 assigned to each group, during the recruitment period from January 2020 to June 2021."
      },
      "Number_Analysed": {
        "score": 2,
        "evidence": "The analysis included 98 participants in the intervention group and 97 in the control group, following an intention-to-treat approach."
      },
      "Result_Outcome": {
        "score": 3,
        "evidence": "The intervention group experienced a significant reduction in postoperative bleeding (mean difference = 5.2 mL, 95% CI 3.1 to 7.3; p = 0.01)."
      },
      "Harms": {
        "score": 1,
        "evidence": "Adverse events were observed in 3% of the intervention group and 1% of the control group, with mild gastrointestinal side-effects reported."
      },
      "Trial_Registration": {
        "score": 0,
        "evidence": "Trial registration: N/A"
      },
      "Funding": {
        "score": 0,
        "evidence": "Funding: The study was funded by [source not provided]."
      }
    },
    "total_score": 19,
    "max_score": 25
  },
  "model": "gpt-4o"
}